Shared Solutions®—the go-to resource for coverage and financial questions about AUSTEDO.

Treat your tardive dyskinesia (TD) for as little as $0

Take advantage of your first 30 days free with our Free Trial Offer.* Then you may be able to reduce your monthly out-of-pocket costs for TD treatment to as little as $0 with the AUSTEDO Copay Program. Sign up for Shared Solutions and we’ll navigate financial options for you.

AUSTEDO® Copay program.
AUSTEDO® Copay program.

The copay card program is for eligible individuals with a valid AUSTEDO prescription. Please note this offer is not available for patients eligible for Medicare, Medicaid or any other government payer coverage. Please review complete Terms and Conditions.

The 30-day Free Trial Voucher is only for new patients. Voucher is good for up to 4 weeks of titration or 30 days of medication.

AUSTEDO® Copay program.
AUSTEDO® Copay program.

Take advantage of support services

Sign up to receive options for financial assistance, nurse support, and benefits coverage

Purple phone ringing icon.
1-800-887-8100

M-F 8AM to 8PM CT

Enroll now

Start AUSTEDO with us, we’ll help you find your financial path forward.

    All new patients prescribed AUSTEDO are eligible for a 30-day free trial voucher.
  • Voucher is good for up to 4 weeks of titration or 30 days of medication.
A woman speaking on the phone.
Man with barcode scanner scanning a label posted on a brown box. Man with barcode scanner scanning a label posted on a brown box.

Receive updates

Sign up to have information about AUSTEDO and tardive dyskinesia emailed to you.

REGISTER NOW

You are about to leave this site

You are about to leave AUSTEDO.com and enter a website operated by a third party. Teva is not responsible for and does not control the content contained on this third-party website linked to AUSTEDO.com.

Are you a healthcare professional?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?

References: 1. Data on file. Parsippany, NJ; Teva Neuroscience, Inc.